Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.
Protecting against both liver and blood stages of infection is a long-sought goal of malaria vaccine design. Recently, we described the use of replication-defective viral vaccine vectors expressing the malaria antigen merozoite surface protein-1 (MSP-1) as an antimalarial vaccine strategy that elici...
প্রধান লেখক: | Draper, S, Goodman, A, Biswas, S, Forbes, E, Moore, A, Gilbert, S, Hill, A |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2009
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria (vol 5, pg 95, 2009)
অনুযায়ী: Draper, S, অন্যান্য
প্রকাশিত: (2011) -
The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment
অনুযায়ী: Goodman, A, অন্যান্য
প্রকাশিত: (2013) -
Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
অনুযায়ী: Biswas, S, অন্যান্য
প্রকাশিত: (2012) -
Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
অনুযায়ী: Forbes, E, অন্যান্য
প্রকাশিত: (2011) -
Effective induction of high-titer antibodies by viral vector vaccines.
অনুযায়ী: Draper, S, অন্যান্য
প্রকাশিত: (2008)